STOCK TITAN
  1. Home
  2. MIRO

Miromatrix Medical (MIRO) Stock Price, News & Analysis

MIRO NASDAQ

Company Description

Miromatrix Medical (NASDAQ: MIRO) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for MIRO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
27.4M
Shares outstanding

Latest News

View All
0.00%

United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger

acquisition
+0.59%

United Therapeutics and Miromatrix Medical Announce Successful Tender Offer

0.00%

Miromatrix Reports Third Quarter 2023 Results

earnings
+216.35%

United Therapeutics to Acquire Miromatrix Medical

acquisition
-1.63%

Miromatrix to Present at the 2023 ISODP Organ Donation Congress

conferences
-0.86%

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa

conferences

Miromatrix Medical has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, conferences. View all MIRO news →

SEC Filings

View All

No SEC filings available for MIRO.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MIRO Company Profile & Sector Positioning

Miromatrix Medical (MIRO) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.